SEARCH BY
Try For Free 7-Day Free Trial
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 35 of 36 |
| Sector (Information Technology) | 1 of 1 |
| Type (Going Private) | 3 of 3 |
| Country (United Kingdom) | 4 of 4 |
| Year (2023) | 3 of 3 |
| Size (of disclosed) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-17 |
Symbio Proinnovera
Jefferson, New York, United States Symbio Proinnovera is a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client’s dermatology and aesthetics services – from pre-clinical formulation work to subsequent clinical trial execution. Symbio Proinnovera is based in Jefferson, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-09 |
AnteAGE
Irvine, California, United States AnteAGE is a skincare company, developing and manufacturing science-backed skincare products based on growth factors and exosomes. Exosomes are extracellular vesicles naturally produced in the human body, that contribute to cell-to-cell communication by transferring to counterpart cells biological signals and by thus can affect and regulate cell growth, development, and repair. AnteAGE was formed in 2009 and is based in Irvine, California. |
Buy | - |
